Navigation Links
New England Journal of Medicine Publishes New Data on Gardasil,,Merck's Cervical Cancer Vaccine

rformance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2006, and in its periodic reports on Form 10-Q and Form 8-K, which the Company incorporates by reference.

GARDASIL(R) is a registered trademark of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.

Prescribing information and patient product information for GARDASIL(R) is attached and is also available at www.gardasil.com. -0-

MERCK & CO., INC.

Whitehouse Station, NJ 08889, USA                              9682301

----------------------------------------------------------------------


GARDASIL(R)

(Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant

Vaccine)


DESCRIPTION


    GARDASIL* is a non-infectious recombinant, quadrivalent vaccine

prepared from the highly purified virus-like particles (VLPs) of the

major capsid (L1) protein of HPV Types 6, 11, 16, and 18. The L1

proteins are produced by separate fermentations in recombinant

Saccharomyces cerevisiae and self-assembled into VLPs. The

fermentation process involves growth of S. cerevisiae on

chemically-defined fermentation media which include vitamins, amino

acids, mineral salts, and carbohydrates. The VLPs are released from

the yeast cells by cell disruption and purified by a series of

chemical and physical methods. The purified VLPs are adsorbed on

preformed aluminum-containing adjuvant (amorphous aluminum

hydroxyphosphate sulfate). The quadrivalent HPV VLP vaccine is a

sterile liquid suspension that is prepared 
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
2. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
7. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
8. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
9. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
10. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics

Post Your Comments:
(Date:11/24/2009).../--ChindexInternational,Inc.,("Chindex")(Nasdaq: C...,healthcareproductsandservicesinthePeople,sRepubli...e21stAnnualPiperJaffray,"Unplugged"HealthCareConfe...Hotel. , Managementiscurrentlyscheduledtopres...-on-onemeetingsthroughouttheday.Awebcast,ofthepres...
(Date:11/24/2009)...stCall/--Endologix,Inc.(Nasdaq: ELGX ),developerof...uncedtodaythatithasfiledamotiontostay,ordiscontinu...ghtagainstitinOctober2009byCook,Inc.Themotionwasfi...diana. ,, Endologixhasrequestedthatthestayremai...ice(USPTO)conductsproceedingstore-examinethetwopat...
(Date:11/24/2009)...rstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ)a...isclosureStatementtoday,November24,2009,withtheUni...hearingtoconsiderapprovaloftheDisclosureStatementi...gontheconfirmationofthePlanscheduledforJanuary7,20...nfull.ThePlanisexpected,ifapproved,toallowholderso...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Indiana Drug Card to Provide Free Drug Cards to Residents 53014 1Indiana Drug Card to Provide Free Drug Cards to Residents 53014 2New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011 53012 1New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011 53012 2Urine Test for Chlamydia Shown Effective in Men 53011 1
...aunch Progress and Adlea R...all Today at 11:30 am ET, SOUTH SAN FRANCISCO, Ca...nced today that the company will restructure,opera...t development to,accelerate its transition to a sp...e company also provided updates on Zingo launch pr...
...d That Multaq(R) (Dronedarone) Decreased the Risk,...ion or Atrial Flutter,Already Adequately Treated b...oc analysis of the data from the ATHENA study,were...ion of the European,Society of Cardiology congress...he landmark ATHENA study have shown that the inves...
Other Medicine Technology:Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5
(Date:11/26/2009)... Research Triangle Dental (RTDe...North Carolina, today announced the expansion of i...MINEER Dentist, Dr. Doug Macmillan. , ...angle Dental is pleased to announce that Dr. Doug ...ently completed an additional advanced training se...
(Date:11/25/2009)..., EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/--...uncedthatthecompanywillhosttwoinvestoreventsinDece...-9:00a.m.CT/10:00a.m.ET ,, Principalinvestiga...omibinrelapsedand/orrefractorymultiplemyeloma,asfe...ualMeetingandExpositioninNewOrleans,LA.Theteleconf...
(Date:11/25/2009)..., LOSANGELES,Nov.25/PRNewswire-USNewswire/--TheBla...stodetermineexecutiveleadershipfor2010. ,, Then...pecialtiesinpublicpolicy,law,finance,governmenthea...TheBoardalsocomesfromawiderangeofpersonalbackgroun...somelivingwithHIVthemselves,andrepresentingmultipl...
(Date:11/25/2009)...fortuitous discovery that grew out of a collaborat...tentially offer hope to the nearly 10 million Amer... , Also known as hardening of the arteries, ...irculatory problem in which narrowed arteries redu...dered a red flag for vascular disease, heart attac...
(Date:11/25/2009)...e, forgetfulness could lead mothers to overlook ne...v. 25 (HealthDay News) -- A mother,s depression ca... found. , Their six-month study of 262 black mo... mothers had more depressive symptoms had more fre...ith fewer depressive symptoms had less frequent as...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
... A new drug, ADDERALL XR? has been found to improv...ntion in young adults with attention-deficit/hyper...een presented at the 18th Annual U.S. Psychiatric ... Accidents are the leading cause of death until ag...
... Recent research findings suggest that reflecting ...chological responses to stress at low levels. S...ession of a broad array of mental and physical hea...d in the November issue of the journal Psychologic...
... An article published in the November issue of the...kah or a water pipe has the same effect on the gum...al disease and are equally devastating as far as t... that the impact of the water pipe is largely simi...
... Taxotere which is the choice of drug for patients...ve their choice to choose this drug as the Scottis...he drug is very expensive and it does not have muc...ry good effect in reducing tumor burden in these p...
... Several religious luminaries have expressed conce...ion that has resulted in a sharp decline in girl p...nt is believed to put an end to the practice of ge...the Art of Living Foundation spiritual head Sri Sr...
... A study in the US shows that exposure to on-scree...r in determining whether young people will take up...researchers from the Dartmouth Medical School (DMS...king accounted for smoking initiation among over o...
Other Medicine News:Health News:New Drug Found To Improve Driving Performance In Young Adults With ADHD 2Health News:Imbalance In Gender Ratio Addressed By Religious Leaders 2
DIX Foreign Body Spud
...age lens is made from MMA/VP material and has a hi...th the base curve and total diameter as specified ...ower range of -30.00DS to +30.00DS,Simplon Ba...d therapeutic applications including the controlle...
Ellis Needles
Bandage
Medicine Products: